Fix your skin and pain problems at the source
  • No products in the cart.
Search result for:


Aevum is led by serial entrepreneur and clinical researcher, Christina DiArcangelo. DiArcangelo is the Founder and CEO of Affinity Bio Partners, and CEO of Spectral Analytics Precision Tele-Monitoring. 

Both companies place a strong emphasis on bringing quality, safe, and effective clinical research to the forefront of the global biotech and clinical research community. If you are interested in learning more about the work that Aevums leaders are involved in, and their dedication to global clinical research, and putting people and patients first, click through some of the recent press below.

3 Ways Brands Can Enhance a Cannabis Consumer’s Experience
Using Research & Data to Better Serve Cannabis Patients
Vanguard Media Online - Christina DiArcangelo
Mental Health, Clinical Research, and Cannabis: How They Are All Linked Together
Global Cannabis Times - Benchmarks - Diana-Ashley Krach
Life Science Success Christina DiArcangelo (CEO and Founder of Affinity Bio Partners)
Firm Begins Testing Cannabis as Diabetic Nerve Pain Treatment